![David Simmons](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Simmons
Consultor / Asesor en Abingworth Management, Inc. .
Origen de la red de primer grado David Simmons.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Abingworth Management, Inc.
![]() Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA.
12
| Subsidiary | Investment Managers | 12 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a David Simmons a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Quintiles Transnational Corp.
![]() Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
STANDARD BIOTOOLS INC. | Medical Specialties | Chairman | |
Elan Pharmaceuticals, LLC
![]() Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | President | |
Eventide Asset Management LLC
![]() Eventide Asset Management LLC Investment ManagersFinance Eventide Asset Management LLC (Eventide) is an independent, SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 2008 by Finni Kuruvilla, Jason Myhre, Roben John, David Barksdale and Anil Thomas. Eventide provides portfolio management for registered mutual funds and offers non-discretionary Model Allocations and Models to financial intermediaries such as wrap fee program sponsors. | Investment Managers | Analyst-Equity | |
MALLINCKRODT PLC | Pharmaceuticals: Major | Director/Board Member | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
OPTHEA LIMITED | Biotechnology | Director/Board Member | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GE Healthcare Ltd. (United Kingdom)
![]() GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
The University of Texas at Austin | College/University | Undergraduate Degree | |
The Johns Hopkins University | College/University | Graduate Degree | |
Gerson Lehrman Group, Inc.
![]() Gerson Lehrman Group, Inc. Miscellaneous Commercial ServicesCommercial Services Gerson Lehrman Group, Inc. provides membership network for learning and expertise. The firm promotes knowledge exchange through conversations, small group convenings, mentorships, surveys, and other interactions with its network of experts. The company was founded by Alexander Saint-Amand, Thomas D. Lehrman, and Mark Gerson in 1998 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Universidad Complutense de Madrid | College/University | Doctorate Degree | |
Accelerator Services Corp
![]() Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investment Managers | Consultant / Advisor | |
Lilly Research Laboratories
![]() Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ysios Capital Partners SGEIC SA
![]() Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor | |
IMMUNE DESIGN CORP | Pharmaceuticals: Major | Chief Executive Officer | |
THE CARLYLE GROUP INC. | Investment Managers | Corporate Officer/Principal | |
SAMSUNG BIOLOGICS CO.,LTD. | Biotechnology | Director/Board Member | |
Evidera, Inc.
![]() Evidera, Inc. Miscellaneous Commercial ServicesCommercial Services Evidera, Inc. engages in provision of health economics, outcomes research, market access, data analytics and epidemiology services. It offers software for real-world data analytics, meta research, modeling and simulation, outcomes research, patient preferences, payer communications and strategy, precision and transformative technology solutions, and value and evidence planning. The company was founded in 2013 and is headquartered in Bethesda, MD. | Miscellaneous Commercial Services | President | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
TriNetX, LLC
![]() TriNetX, LLC Medical/Nursing ServicesHealth Services TriNetX, Inc. provides an online data network for collaborative research. It enables hospitals, academic medical centers, physician networks, practices, and pharmaceuticals to participate in collaborative research and a public and private sustainability model for research informatics. The company was founded by Bard Geesaman in 2013 and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director/Board Member | |
VAXCYTE, INC. | Biotechnology | Chairman | |
IFM Therapeutics LLC
![]() IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology IFM Therapeutics LLC engages in the development and transformation of immunotherapy for patients with serious diseases. It focuses on developing small molecule drugs that target the innate immune system. The company was founded by Gary D. Glick, Luigi Franchi, Matthias Geyer, Eicke Latz, and Anthony W. Opipari, Jr. in 2015 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Founder | |
Bain Capital Life Sciences LP
![]() Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst | |
Mallinckrodt Pharmaceuticals Ltd.
![]() Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015. | Pharmaceuticals: Major | Director/Board Member | |
PPD, INC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Delin Ventures Ltd.
![]() Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Investment Managers | Consultant / Advisor | |
Highlight Therapeutics SL
![]() Highlight Therapeutics SL Pharmaceuticals: MajorHealth Technology Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain. | Pharmaceuticals: Major | Chairman | |
Novartis Inflammasome Research, Inc.
![]() Novartis Inflammasome Research, Inc. Pharmaceuticals: MajorHealth Technology Novartis Inflammasome Research, Inc. operates as a biopharmaceutical company, which engages in the development of a suite of NOD-, LRR- and pyrin domain-containing 3 (NLRP3) antagonists for the treatment of inflammatory diseases. It also develops chemically distinct systemic, gut-directed, and central nervous system (CNS)-penetrant drug candidates to address a breadth of indications triggered by NLRP3, including metabolic, fibrotic, autoimmune, autoinflammatory, and neurological diseases. The company was founded by Eicke Latz and Luigi Franchi in 2017 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
First Wave Bio, Inc.
![]() First Wave Bio, Inc. Miscellaneous Commercial ServicesCommercial Services First Wave Bio, Inc. develops novel therapeutics for the treatment of inflammatory bowel disease. The company was founded by Gary D. Glick, Anthony W. Opipari, Luigi Franchi in 2015 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder | |
Nido Biosciences, Inc.
![]() Nido Biosciences, Inc. BiotechnologyHealth Technology Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Scorpion Therapeutics, Inc.
![]() Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Founder | |
Trishula Therapeutics, Inc.
![]() Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Atsena Therapeutics, Inc.
![]() Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
Odyssey Therapeutics, Inc.
![]() Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation. | Packaged Software | Founder | |
JASPER THERAPEUTICS, INC. | Financial Conglomerates | Director/Board Member | |
Launch Therapeutics, Inc.
![]() Launch Therapeutics, Inc. Financial ConglomeratesFinance Launch Therapeutics, Inc. provides investment and therapies development services. The CEO of the American company is Anshul Thakral. | Financial Conglomerates | Chief Executive Officer | |
FORTE BIOSCIENCES, INC. | Biotechnology | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 34 |
Reino Unido | 4 |
España | 4 |
Irlanda | 3 |
Australia | 2 |
Sectorial
Health Technology | 21 |
Finance | 9 |
Commercial Services | 8 |
Consumer Services | 6 |
Health Services | 3 |
Operativa
Director/Board Member | 70 |
Corporate Officer/Principal | 19 |
Private Equity Investor | 15 |
President | 13 |
Chief Executive Officer | 11 |
Las relaciones más conectadas
Insiders | |
---|---|
Shelley Chu | 31 |
Vincent J. Miles | 17 |
John Chiminski | 17 |
Gary D. Glick | 16 |
Carlos Paya | 14 |
Anshul Thakral | 13 |
Scott Brun | 12 |
Joy Ghosh | 8 |
James Cornwall | 3 |
Jackie Grant | 3 |
Kurt Emster | 2 |
Jay Cui | 1 |
- Bolsa de valores
- Insiders
- David Simmons
- Conexiones Empresas